Haisco

002653

----

Current ValuationThe current P/E ratio is 70.55, below the reasonable range, cheaper than 91.04% of the time in the past 3 years, and the industry ranks 133/223, the industry Median 21.76.

70.55xP/E

Stock price¥58.70Earnings per share¥0.83

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 21.76x

018365472

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 21.76x

0x40x80x120x160x200x

P/E ratio
Name/Symbol
002653SZHaisco	70.55x	512.04%	¥66.97B
301569SZNOVAST	63.37x	--	¥16.84B
603858SHBUCHANG PHARMA	66.85x	--	¥15.76B
002399SZHepalink	67.61x	109.91%	¥13.72B
300723SZApicHope	61.95x	255.12%	¥13.66B
300049SZFurui Co.,Ltd.	61.67x	75.86%	¥10.24B
600812SHNCPC	66.60x	--	¥8.22B
603538SHMenovo	61.46x	--	¥7.18B
300702SZTIANYU PHARM	78.13x	121.95%	¥7.07B
688553SHHUIYU PHARMACEUTICAL	60.99x	--	¥6.92B
603229SHAusun Pharm	76.61x	106.25%	¥6.21B
002907SZPharscin Pharma	60.66x	--	¥5.69B
002728SZTY PHAR.	69.09x	181.25%	¥4.55B
301281SZKeyuan Pharma	63.04x	--	¥4.44B
600628SHSNW	61.31x	--	¥4.20B
002644SZFoci Pharmaceutical	66.83x	--	¥3.93B
002693SZSC Pharmaceuticals	72.09x	--	¥3.69B
600222SHTaloph	69.76x	--	¥3.68B
002365SZYONGAN PHARMACEUTICAL	62.68x	--	¥3.35B
301509SZKingchem	67.74x	--	¥3.06B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.